CMP Pharma is a specialty pharmaceutical company that addresses critical needs for niche markets within the pharmaceutical and life science industries by developing and manufacturing a portfolio of high value semi-solid and liquid products. Our products include leading, high-quality branded and generic prescription, non-prescription and skin care pharmaceutical products, which we distribute to hospital, long-term care, and retail channels.

The History of CMP Pharma

CMP Pharma was founded by Henry Smith as Carolina Medical Products (CMP) Company in 1975 while he was a professor of drug manufacturing at the University of North Carolina at Chapel Hill’s School of Pharmacy. In 1982, CMP’s, SPS® Suspension was the first FDA approved suspension form of Sodium Polystyrene Sulfonate for the treatment of hyperkalemia. Prior to this approval, Sodium Polystyrene Sulfonate was only available as a powder for suspension.

Approvals followed for Isoniazid Oral Solution, USP, the only FDA approved liquid treatment for tuberculosis, as well as Sodium Polystyrene Sulfonate for Suspension.

Other products include:

  • Oracit® – a treatment for metabolic conditions
  • Dermacloud Ointment – an OTC skin protectant
  • Absorbase® – a non-prescription topical ointment for dry skin conditions
  • Simethicone Drops – an OTC agent for relief of symptoms associated with gas in the digestive tract

We’ve manufactured high-quality pharmaceutical products at our Farmville, North Carolina facility since 1986.

About Us

Learn more about what we do at CMP Pharma.

Our Vision

Learn how CMP Pharma fits into specialty niches.


Find out what makes our team so successful.

Markets We Serve

Find out where our products are sold and whom they benefit.